Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.
Tienan ZhouYinghui GongJingyuan LiYasong WangXiao-Zeng WangPublished in: Trials (2023)
This protocol is registered at the Chinese Clinical Trial Registry under the number ChiCTR2100044319. And this publication is based on version 1.4 of the trial protocol dated Sep 6, 2021.
Keyphrases
- percutaneous coronary intervention
- randomized controlled trial
- antiplatelet therapy
- study protocol
- acute coronary syndrome
- coronary artery disease
- clinical trial
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery bypass grafting
- atrial fibrillation
- phase ii
- phase iii
- cardiovascular events
- open label
- coronary artery
- low dose
- venous thromboembolism
- pulmonary embolism
- coronary artery bypass
- pulmonary hypertension
- psychometric properties
- cardiovascular disease
- double blind
- type diabetes
- placebo controlled
- heart failure
- meta analyses